Amylyx Pharmaceuticals (AMLX) Earnings Date, Estimates & Call Transcripts → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free AMLX Stock Alerts $1.76 -0.14 (-7.39%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 9) -$0.46 Missed By -$0.70 Consensus EPS (May. 9) $0.24 Read Call TranscriptListen to Call Get Amylyx Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for AMLX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMLX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMLX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Amylyx Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$0.16$0.32$0.24Q2 20242($0.52)($0.23)($0.38)Q3 20242($0.57)($0.19)($0.38)Q4 20242($0.57)($0.15)($0.36)FY 20248($1.50)($0.25)($0.88)AMLX Earnings Date and InformationAmylyx Pharmaceuticals last released its quarterly earnings results on May 9th, 2024. The reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by $0.70. The company had revenue of $88.64 million for the quarter, compared to the consensus estimate of $113.26 million. Amylyx Pharmaceuticals has generated $0.70 earnings per share over the last year ($0.70 diluted earnings per share) and currently has a price-to-earnings ratio of 2.5. Earnings for Amylyx Pharmaceuticals are expected to decrease in the coming year, from ($1.01) to ($1.10) per share. Amylyx Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Amylyx Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 5/9/2024Q1 2024$0.24($0.46)($0.70)$0.83$113.26 million$88.64 million 2/22/2024Q4 2023$0.20$0.23+$0.03$0.07$106.40 million$108.45 million 11/9/2023Q3 2023$0.42$0.30($0.12)$0.30$113.95 million$102.69 million8/10/2023Q2 2023$0.01$0.31+$0.30$0.31$84.30 million$98.22 million5/11/2023Q1 2023($0.27)$0.02+$0.29$0.02$57.35 million$71.43 million3/13/2023Q4 2022($0.77)($0.65)+$0.12($0.65)$3.05 million$21.89 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.97)($0.92)+$0.05($0.92)-$0.35 million8/11/2022Q2 2022($0.92)($0.93)($0.01)($0.93)--5/12/2022Q1 2022($0.75)($0.93)($0.18)($0.93)-- Amylyx Pharmaceuticals Earnings - Frequently Asked Questions When is Amylyx Pharmaceuticals's earnings date? Amylyx Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on AMLX's earnings history. Did Amylyx Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Amylyx Pharmaceuticals (NASDAQ:AMLX) missed the analysts' consensus estimate of $0.24 by $0.70 with a reported earnings per share (EPS) of ($0.46). Learn more on analysts' earnings estimate vs. AMLX's actual earnings. How can I listen to Amylyx Pharmaceuticals's earnings conference call? The conference call for Amylyx Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Amylyx Pharmaceuticals's conference call transcript? The conference call transcript for Amylyx Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Amylyx Pharmaceuticals generate each year? Amylyx Pharmaceuticals (NASDAQ:AMLX) has a recorded annual revenue of $380.79 million. How much profit does Amylyx Pharmaceuticals generate each year? Amylyx Pharmaceuticals (NASDAQ:AMLX) has a recorded net income of $49.27 million. AMLX has generated $0.70 earnings per share over the last four quarters. What is Amylyx Pharmaceuticals's price-to-earnings ratio? Amylyx Pharmaceuticals (NASDAQ:AMLX) has a trailing price-to-earnings ratio of 2.51. What is Amylyx Pharmaceuticals's EPS forecast for next year? Amylyx Pharmaceuticals's earnings are expected to decrease from ($1.01) per share to ($1.10) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PDS Biotechnology Earnings Results Adicet Bio Earnings Results Sagimet Biosciences Earnings Results Karyopharm Therapeutics Earnings Results Cartesian Therapeutics Earnings Results Citius Pharmaceuticals Earnings Results Societal CDMO Earnings Results GlycoMimetics Earnings Results Vistagen Therapeutics Earnings Results Repare Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:AMLX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.